Company: SHPH
Filing Date: 2025-02-13
Form Type: S-1
Source: 0001493152-25-006202
Chunk: 230

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-13
Form: S-1
Chunk 230
---
 Restricted Stock Units

|                                                  |     | Year ended December 31, 
 2023                    |    2023 |     | 2022         |    2022 |
|:-------------------------------------------------|:----|:------------------------|--------:|:----|:-------------|--------:|
|                                                  |     |                         |         |     | -as restated |         |
| Recognized in general and administrative expense |     | $                       | 115,000 |     | $            | 105,582 |
| Recognized in research and development expense   |     |                         |  66,960 |     |              | 131,965 |
| Total                                            |     | $                       | 181,960 |     | $            | 237,547 |

As of December 31, 2023 and 2022, there was $ 231,550and $ 61,111, respectively, of unrecognized stock-based compensation expense related to unvested RSUs, which is expected to be recognized over a weighted-average period of 1.06years and 1.83years, respectively.

| F-40 |

A summary of activity regarding the Restricted Stock Units issued follows:

Schedule of Restricted Stock Units (RSUs)

|                                              |     | Number of Shares |         |   |     | Weighted Average Grant Date Fair Value Per Share |        |
|:---------------------------------------------|:----|:-----------------|--------:|:--|:----|:-------------------------------------------------|-------:|
| Outstanding, December 31, 2021 (as restated) |     |                  |   2,017 |   |     | $                                                | 185.60 |
| Granted                                      |     |                  |   4,449 |   |     |                                                  |  22.48 |
| Vested (as restated)                         |     |                  |  (3,500 | ) |     |                                                  | 116.48 |
| Outstanding, December 31, 2022 (as restated) |     |                  |   2,966 |   |     | $                                                |  22.48 |
| Granted                                      |     |                  |  32,415 |   |     |                                                  |  10.88 |
| Vested (as restated)                         |     |                  | (10,650 | ) |     |                                                  |  12.00 |
| Outstanding, December 31,